Tech Company Financing Transactions
Neurent Medical Funding Round
Neurent Medical, based in Braintree, raised $25 million from Claret Capital Partners.
Transaction Overview
Company Name
Announced On
9/9/2026
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to support the continued commercial expansion, accelerate investment in sales and marketing initiatives, strengthen its balance sheet, and provide additional capital to support future growth opportunities.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
150 Grossman Drive 203
Braintree, MA 02184
USA
Braintree, MA 02184
USA
Phone
Website
Email Address
Overview
Neurent's proprietary NEUROMARK® technology enables physicians to precisely target and safely disrupt multiple underlying nerve branches to alleviate Chronic Rhinitis (CR) symptoms and improve patient "quality of life". Neurent Medical is pioneering innovative treatments for chronic inflammatory sino-nasal diseases by targeting and safely disrupting hyperactive autonomic nerves that drive underlying inflammation, so patients can breathe better and live better.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 9/9/2026: Actionable venture capital transaction
Next: 9/9/2026: fundcraft venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We report on tech company VC transactions. All VC database entries reported here come from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs








